Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Accumulated Expenses: 2010-2025

Historic Accumulated Expenses for BIO-TECHNE (TECH) over the last 16 years, with Jun 2025 value amounting to $65.8 million.

  • BIO-TECHNE's Accumulated Expenses rose 3.86% to $43.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.6 million, marking a year-over-year increase of 3.86%. This contributed to the annual value of $65.8 million for FY2025, which is 32.06% up from last year.
  • Latest data reveals that BIO-TECHNE reported Accumulated Expenses of $65.8 million as of FY2025, which was up 32.06% from $49.8 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Accumulated Expenses registered a high of $65.8 million during FY2025, and its lowest value of $36.7 million during FY2023.
  • Its 3-year average for Accumulated Expenses is $50.8 million, with a median of $49.8 million in 2024.
  • Per our database at Business Quant, BIO-TECHNE's Accumulated Expenses surged by 65.00% in 2021 and then plummeted by 40.69% in 2023.
  • Over the past 5 years, BIO-TECHNE's Accumulated Expenses (Yearly) stood at $51.3 million in 2021, then grew by 20.78% to $62.0 million in 2022, then plummeted by 40.69% to $36.7 million in 2023, then skyrocketed by 35.57% to $49.8 million in 2024, then skyrocketed by 32.06% to $65.8 million in 2025.